Avesthagen Pharma India Private Limited, a struck off foreign private limited company, was established on 25 September 2012 in Bangalore, Karnataka, India. Engaging in pharma contract r&d within the pharma sector, it holds CIN: U74900KA2012FTC065991. Registered under ROC Roc Bangalore. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.
It upholds a active non-compliant status. Its leadership includes Villoo Zareer Morawala Patell (Director), Daulat Dara Morawala (Additional Director). Past directors included Dhiren Shah, Villoo Zareer Morawala Patell, Bipinkumar Khimasia. Its latest AGM occurred on 29 September 2018, with the balance sheet filed on 31 March 2018. It is based at 9Th Floor, Discoverer International Tech Park, Whitefield Road, Bangalore, Karnataka, 560066.
U74900KA2012FTC065991
065991
25 September 2012
₹0.10 M
₹0.10 M
Roc Bangalore
Unlisted
Struck Off
Explore comprehensive insights into Avesthagen Pharma India Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Villoo Zareer Morawala Patell | Director | 03 Jun 2013 | Current |
| Daulat Dara Morawala | Additional Director | 13 Sep 2019 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 13 Sep 2019 | Past |
| Pramod Abcsdd | Additional Director | 28 Sep 2013 | Past |
| Pramod Abcsdd | Director | 03 Jun 2013 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Avesthagen Pharma India Private Limited, for the financial year ended 2018, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 56.3% increase in profit. The company's net worth observed a substantial decline by a decrease of 72.41%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2018, Avesthagen Pharma India had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Avesthagen Pharma India, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Avesthagen Pharma India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Avesthagen Pharma India's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Daulat Dara Morawala was appointed as a Additional Director was appointed as a Additional Director on 13 Sep 2019 & has been associated with this company since 6 years 4 months . was completed.
Avesthagen Pharma India Private Limited last Annual general meeting of members was held on 29 Sep 2018 as per latest MCA records. was recorded as a recent event.
The activity Avesthagen Pharma India Private Limited has filed its annual Financial statements for the year ended 31 Mar 2018 with Roc Bangalore. was completed.
Villoo Zareer Morawala Patell was appointed as a Director was appointed as a Director on 03 Jun 2013 & has been associated with this company since 12 years 7 months . was recorded as a recent event.
The activity Avesthagen Pharma India Private Limited was registered on 25 Sep 2012 with Roc Bangalore & aged 13 years 3 months as per MCA records. was completed.
The CIN of Avesthagen Pharma India Private Limited is U74900KA2012FTC065991.
Avesthagen Pharma India Private Limited is headquartered at 9Th Floor, Discoverer International Tech Park, Whitefield Road, Bangalore, Karnataka, 560066.
Avesthagen Pharma India Private Limited was incorporated on 25 September 2012.
The current directors of Avesthagen Pharma India Private Limited are
The primary industry of Avesthagen Pharma India Private Limited is Pharma.
Avesthagen Pharma India Private Limited is unlisted.
The authorized capital of Avesthagen Pharma India Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.
The compliance status of Avesthagen Pharma India Private Limited is Active Non-Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX